MECOM and myelodysplastic syndrome: The insertions found in the 2 patients from the X-CGD trial were located in MDS1/EVI1, PRDM16 or SETBP1 and resulted in a pre-myelodysplastic syndrome in combination with the acquisition of monosomy 7 [87,161].